Evaluation of Antibody Response to Heterologous Prime–Boost Vaccination with ChAdOx1 nCoV-19 and BNT162b2: An Observational Study

In several countries, thrombotic events after vaccination with ChAdOx1 nCoV-19 have led to heterologous messenger RNA (mRNA) boosting. We tested the antibody response to SARS-CoV-2 spike protein four weeks after heterologous priming with the ChAdOx1 (ChAd) vector vaccine followed by boosting with BN...

وصف كامل

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Firinu, Davide, Perra, Andrea, Campagna, Marcello, Littera, Roberto, Meloni, Federico, Sedda, Francesca, Conti, Maria, Costanzo, Giulia, Erbi, Monica, Usai, Gianmario, Locci, Carlotta, Carta, Mauro Giovanni, Cappai, Riccardo, Orrù, Germano, Del Giacco, Stefano, Coghe, Ferdinando, Chessa, Luchino
التنسيق: Online مقال نص
اللغة:English
منشور في: MDPI 2021
الموضوعات:
Article
الوصول للمادة أونلاين:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8704060/
https://www.ncbi.nlm.nih.gov/pubmed/34960224
http://dx.doi.org/10.3390/vaccines9121478

الانترنت

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8704060/
https://www.ncbi.nlm.nih.gov/pubmed/34960224
http://dx.doi.org/10.3390/vaccines9121478

مواد مشابهة